What is Agilent Technologies, Inc. (A)?

Agilent Technologies, Inc. (A) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

What is the current price of A?

The current price of A is $181.47. Prices are updated in real time on Stocks360.

What is A's price-to-earnings (PE) ratio?

A's trailing twelve-month PE ratio is 35.65, based on current price and earnings per share data available on Stocks360.

What is A's market capitalization?

A's market capitalization is $51,168,336,429.00, placing it in the large-cap tier.

Does A pay a dividend?

Yes. A has a trailing twelve-month dividend yield of 0.01%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Agilent Technologies, Inc. (A)

Stock analysis · NYSE · Healthcare · Medical - Diagnostics & Research

$181.47

Market Cap

$51.17B

PE (TTM)

35.65

EPS (TTM)

N/A

Dividend Yield

0.56%

Beta

1.21

Day Range

$176.87 – $182.93

52-wk Range

$108.35 – $182.92

Avg Volume

N/A

Volume

506.12K

Agilent Technologies, Inc. (A) is a publicly traded company in the Healthcare sector. Latest price: $181.47. Market cap $51.17B. Trailing PE 35.65. Dividend yield 0.56%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $145.85 2026-10-28 · $182.01 (+24.79%)

Earnings

Most Recent

Aug 26, 2026

EPS $1.62 vs est. $1.49

Beat by $0.13

Next Earnings

Nov 23, 2026

EPS estimate $1.72

Proprietary Signals

Signal snapshot temporarily unavailable.

About Agilent Technologies, Inc.

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	35.65×
P/S (TTM)	6.94×
P/B	6.95×
PEG	1.88×
P/FCF (TTM)	35.63×
EV / EBITDA	26.22×
EV / Sales	7.24×
Earnings Yield	2.81%
Free Cash Flow Yield	2.81%
Dividend Yield	0.56%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$53.36B
Revenue (TTM)	$7.37B
Net Income (TTM)	$1.44B
Free Cash Flow (TTM)	$1.53B
Net Debt	$2.19B
Working Capital	$2.40B
Gross Margin	53.73%
Operating Margin	22.23%
Net Margin	19.53%
Return on Equity	20.47%
Return on Invested Capital	11.88%